Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 2.08
- Piotroski Score 6.00
- Grade Outperform
- Symbol (CVS)
- Company CVS Health Corporation
- Price $56.08
- Changes Percentage (5.43%)
- Change $2.89
- Day Low $53.45
- Day High $56.78
- Year High $83.25
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
- Last Earnings 09/19/2024
- Ex-Dividend for 5/16 Dividend 10/21/2024
- Dividend Payable 11/01/2024
- Today N/A
- Next Earnings (Estimated) 02/05/2025
- Fiscal Year End N/A
- Average Stock Price Target $105.00
- High Stock Price Target $127.00
- Low Stock Price Target $63.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $5.70
- Trailing P/E Ratio 10.84
- Forward P/E Ratio 10.84
- P/E Growth 10.84
- Net Income $8.34 B
Income Statement
Quarterly
Annual
Latest News of CVS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
CVS Health (NYSE:CVS) sheds US$3.0b, company earnings and investor returns have been trending downwards for past three years
Long-term investors in CVS Health Corporation have experienced a 43% decline in share price over three years, falling short of market performance. Recent poor financial results may have caused this. A...
By Yahoo! Finance | 2 days ago -
CVS Health Path Forward Becomes Clearer And Breakup Is Unlikely
CVS Health's CEO, David Joyner, dismissed rumors of a company breakup. He emphasized the importance of their diversified portfolio, focusing on improving Aetna's performance and maintaining their thre...
By Forbes | 1 week ago -
CVS Health Corporation Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
CVS Health's third-quarter earnings fell short of expectations, with revenue slightly exceeding forecasts. Analysts expect a 5.1% revenue increase and a 43% surge in per-share earnings by 2025. Despit...
By Yahoo! Finance | 1 week ago
